{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Alanine aminotransferase", "Aspartate aminotransferase", "Diabetes", "Hesperetin", "Hesperetin (PubChem CID: 72281)", "Hesperidin", "Hesperidin (PubChem CID: 10621)", "Molecular docking"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "28385612", "DateCompleted": {"Year": "2017", "Month": "06", "Day": "29"}, "DateRevised": {"Year": "2017", "Month": "06", "Day": "29"}, "Article": {"ArticleDate": [{"Year": "2017", "Month": "04", "Day": "03"}], "Language": ["eng"], "ELocationID": ["10.1016/j.lfs.2017.04.001", "S0024-3205(17)30119-4"], "Journal": {"ISSN": "1879-0631", "JournalIssue": {"Volume": "178", "PubDate": {"Year": "2017", "Month": "Jun", "Day": "01"}}, "Title": "Life sciences", "ISOAbbreviation": "Life Sci"}, "ArticleTitle": "Inhibition of liver alanine aminotransferase and aspartate aminotransferase by hesperidin and its aglycone hesperetin: An in vitro and in silico study.", "Pagination": {"StartPage": "49", "EndPage": "55", "MedlinePgn": "49-55"}, "Abstract": {"AbstractText": ["This study aimed to investigate the inhibitory effects of two natural flavonoids, hesperetin (HT) and hesperidin (HD), on two gluconeogenesis enzymes, alanine aminotransferase (ALT) and aspartate aminotransferase (AST) activities and their possible mechanisms of action.", "Rat liver incubated with different concentrations of HT and HD was used to measure enzyme activities spectrophotometrically, based on monitoring the oxidation of NADH to NAD<sup>+</sup> at 340nm. Molecular docking simulation was also applied to reveal the molecular mechanism of the inhibition caused by HT and HD.", "Both flavonoids demonstrated inhibitory effects against the enzyme activities, with IC<sub>50</sub> values of 153.9 and 68.88\u03bcM for HT-ALT and HD-ALT treatment respectively. Likewise, the IC<sub>50</sub> values of 85.29\u03bcM for HT-AST and 110.3\u03bcM for HD-AST were obtained from spectrophotometric results.", "The docking simulation revealed that HT and HD block the enzyme entrance channel and prevent the substrates from accessing the enzyme active sites. Having prevented production of pyruvate, \u03b1-ketoglutarate, and the oxaloacetate, these two compounds inhibit hepatic gluconeogenesis and consequently, hinder the progression of diabetes.", "This study suggests that HT and HD may be considered as leading compounds for designing safe and effective drugs in management of increased ALT and AST-related disorders specially diabetes."], "CopyrightInformation": "Copyright \u00a9 2017 Elsevier Inc. All rights reserved."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biochemistry, Kharazmi University, Mofateh Ave., Tehran, Iran."}], "LastName": "Zareei", "ForeName": "Sara", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biochemistry, Kharazmi University, Mofateh Ave., Tehran, Iran."}], "LastName": "Boojar", "ForeName": "Massoud M A", "Initials": "MMA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medicinal Chemistry, Faculty of Pharmacy and Medicinal Plants Research Center, Tehran University of Medical Sciences, 16 Azar Ave., Tehran, Iran. Electronic address: amanlou@tums.ac.ir."}], "LastName": "Amanlou", "ForeName": "Massoud", "Initials": "M"}], "PublicationTypeList": ["Comparative Study", "Journal Article"]}, "MedlineJournalInfo": {"Country": "Netherlands", "MedlineTA": "Life Sci", "NlmUniqueID": "0375521", "ISSNLinking": "0024-3205"}, "ChemicalList": [{"RegistryNumber": "E750O06Y6O", "NameOfSubstance": "Hesperidin"}, {"RegistryNumber": "EC 2.6.1.1", "NameOfSubstance": "Aspartate Aminotransferases"}, {"RegistryNumber": "EC 2.6.1.2", "NameOfSubstance": "Alanine Transaminase"}, {"RegistryNumber": "Q9Q3D557F1", "NameOfSubstance": "hesperetin"}], "MeshHeadingList": [{"QualifierName": ["pharmacology"], "DescriptorName": "Alanine Transaminase"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["antagonists & inhibitors"], "DescriptorName": "Aspartate Aminotransferases"}, {"QualifierName": ["drug therapy", "enzymology"], "DescriptorName": "Diabetes Mellitus"}, {"QualifierName": [], "DescriptorName": "Drug Design"}, {"QualifierName": ["drug effects"], "DescriptorName": "Gluconeogenesis"}, {"QualifierName": ["administration & dosage", "pharmacology"], "DescriptorName": "Hesperidin"}, {"QualifierName": [], "DescriptorName": "Inhibitory Concentration 50"}, {"QualifierName": ["drug effects", "enzymology"], "DescriptorName": "Liver"}, {"QualifierName": [], "DescriptorName": "Molecular Docking Simulation"}, {"QualifierName": [], "DescriptorName": "Rats"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2017", "Month": "1", "Day": "29"}, {"Year": "2017", "Month": "3", "Day": "24"}, {"Year": "2017", "Month": "4", "Day": "1"}, {"Year": "2017", "Month": "4", "Day": "8", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "7", "Day": "1", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "4", "Day": "8", "Hour": "6", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["28385612", "10.1016/j.lfs.2017.04.001", "S0024-3205(17)30119-4"]}}]}